Kailera plans IPO for Phase 3 obesity drug from Hengruinews2026-03-29T23:05:55+00:00March 29th, 2026|Endpoints News|
AFPM ’26: US MMA supply to be tighter in Q2news2026-03-29T21:58:00+00:00March 29th, 2026|Independent Commodity Intelligence Services (ICIS)|
AFPM ’26: Canada has unlimited chem feedstocks amid war-driven shortagesnews2026-03-29T19:48:00+00:00March 29th, 2026|Independent Commodity Intelligence Services (ICIS)|
AFPM ’26: Geographic diversity of supply puts Alberta in spotlight amid Middle East crisisnews2026-03-29T19:19:00+00:00March 29th, 2026|Independent Commodity Intelligence Services (ICIS)|
AFPM ’26: All four reactors running at Roehm US MMA unitnews2026-03-29T16:30:00+00:00March 29th, 2026|Independent Commodity Intelligence Services (ICIS)|
#ACC26: Merck leans toward lower Winrevair dose in Phase 3 trial for rare form of heart failurenews2026-03-29T16:00:49+00:00March 29th, 2026|Endpoints News|
AFPM ’26: TSCA chem safety program could get reforms in 2026news2026-03-29T15:35:00+00:00March 29th, 2026|Independent Commodity Intelligence Services (ICIS)|
